
CEO at Gilman Hill Asset Management
Member since: Sep '21 · 293 Opinions
She owns both, and they're merging. Definitely, there will be a regulatory fight. When the deal was announced D share rose 10% and NEE fell 10%. She bought the NEE convertibles (7% dividend). NEE has 8-9% earnings growth and the deal will improve that; trades at 18x PE. Synergies will happen. If the deal doesn't happen, then fine, NEE shares will recover 10%.
She owns both, and they're merging. Definitely, there will be a regulatory fight. When the deal was announced D share rose 10% and NEE fell 10%. She bought the NEE convertibles (7% dividend). NEE has 8-9% earnings growth and the deal will improve that; trades at 18x PE. Synergies will happen. If the deal doesn't happen, then fine, NEE shares will recover 10%.
She hopes healthcare stocks rebound; they've been up this year and being beaten down for a long time. BMY is +19% this year. Trades below 10x PE and produce $11 billion free cash flow this year, $15 billion in 2027, pays over a 4% dividend. There's value here. With their cash flow, they can buy their way to growth.